Viyash Scientific · NSE: VIYASH · BSE: 512529
Q4 FY24 results · Jan–Mar 2024
Viyash Scientific reported revenue from operations of ₹361.20 crore (down 1.5% from Q4 FY23) and net profit of ₹1.27 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 361.20 | 366.67 | −1.5% | 329.36 | +9.7% |
| Other income | 4.00 | 1.74 | +130.2% | 4.52 | −11.5% |
| Total income | 365.19 | 368.40 | −0.9% | 333.88 | +9.4% |
| Profit before tax | 2.64 | (88.80) | Turned profit | 1.49 | +76.8% |
| Net profit for the period | 1.27 | (92.44) | Turned profit | 10.68 | −88.1% |
| Attributable to shareholders of the company | (0.91) | (93.57) | Loss narrowed | 8.27 | Turned loss |
| EPS, basic (₹) | (0.04) | (3.77) | not comparable | 0.33 | not comparable |
| Net margin (%) | 0.4 | -25.2 | 3.2 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 36.77 | 46.59 | −21.1% | 42.20 | −12.9% |
| Other income | 12.97 | 8.01 | +61.9% | 13.44 | −3.5% |
| Total income | 49.75 | 54.61 | −8.9% | 55.65 | −10.6% |
| Profit before tax | 4.10 | (1.23) | Turned profit | 6.09 | −32.7% |
| Net profit for the period | 3.76 | (1.65) | Turned profit | 4.58 | −17.8% |
| EPS, basic (₹) | 0.15 | (0.07) | Turned profit | 0.18 | −18.5% |
| Net margin (%) | 10.2 | -3.5 | 10.9 |
Consolidated
- Filed with BSE
- 17 May 2024, 12:24 IST
- Board meeting
- 15 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 May 2024, 12:24 IST
- Board meeting
- 15 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE